tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

BioCryst Pharmaceuticals Inc

BCRX
Add to Watchlist
8.980USD
-0.260-2.81%
Close 07-31 16:00（ET）Quotes delayed by 15 min
2.28BMarket Cap
LossP/E TTM

BioCryst Pharmaceuticals Inc

8.980
-0.260-2.81%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

BCRX Financials

See BioCryst Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

BioCryst Pharmaceuticals Inc Earnings Date

Latest Release
Aug 5, 2026
EPS / Forecast
--/0.12
Revenue / Forecast
--/182.51M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
874.84M
94.10%
EPS(YoY)
1.26
392.35%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-1986446.67%-2.98
1001.90%1.17
190.49%0.06
139.53%0.02
100.09%0.00
57.83%-0.13
64.42%-0.07
84.58%-0.06
39.32%-0.17
19.95%-0.31
---0.19
---0.40
---0.28
---0.38
---0.95
----
----
----
----
----
Revenue
7.48%156.41M
209.09%406.56M
36.14%159.40M
49.41%163.35M
56.89%145.53M
40.83%131.53M
34.98%117.08M
32.54%109.33M
34.87%92.76M
17.42%93.40M
14.39%86.74M
25.88%82.49M
37.77%68.78M
68.68%79.55M
84.97%75.83M
31.17%65.53M
161.94%49.92M
1074.25%47.16M
571.81%40.99M
1640.13%49.96M
Net Profit
-2255762.50%-721.81M
1017.50%245.84M
191.92%12.90M
140.12%5.08M
100.09%32.00K
56.59%-26.80M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.20M
70.61%-17.78M
-27.51%-58.80M
-11.89%-43.20M
Net Margin
-2098682.40%-461.48%
396.84%60.47%
167.52%8.09%
126.85%3.11%
100.06%0.02%
69.18%-20.37%
71.24%-11.99%
87.31%-11.59%
50.81%-38.14%
26.51%-66.09%
---41.67%
---91.31%
---77.54%
---89.94%
---91.79%
----
----
----
----
----
Gross Margin
-0.31%96.56%
2.43%97.66%
1.42%98.63%
-0.13%98.29%
-1.66%96.86%
-2.96%95.34%
-1.47%97.24%
-0.44%98.41%
-0.14%98.50%
1.43%98.25%
--98.69%
--98.85%
--98.64%
--96.86%
--97.86%
----
----
----
----
----
Debt to assets ratio
6.33%181.72%
-46.33%91.11%
-10.92%151.05%
-10.33%159.68%
-5.16%170.91%
4.57%169.76%
6.43%169.57%
15.17%178.07%
22.99%180.21%
21.77%162.35%
--159.33%
--154.62%
--146.53%
--133.32%
--127.76%
----
----
----
----
----
Income Statement
Revenue
7.48%156.41M
209.09%406.56M
36.14%159.40M
49.41%163.35M
56.89%145.53M
40.83%131.53M
34.98%117.08M
32.54%109.33M
34.87%92.76M
17.42%93.40M
14.39%86.74M
25.88%82.49M
37.77%68.78M
68.68%79.55M
84.97%75.83M
31.17%65.53M
161.94%49.92M
1074.25%47.16M
571.81%40.99M
1640.13%49.96M
Operating profit
-118.08%-3.84M
5876.06%260.38M
284.70%29.59M
239.98%29.79M
246.51%21.23M
89.44%-4.51M
164.52%7.69M
142.32%8.76M
49.01%-14.49M
7.86%-42.67M
31.67%-11.92M
40.37%-20.70M
43.12%-28.41M
11.24%-46.31M
60.87%-17.45M
-17.38%-34.72M
2.76%-49.96M
0.44%-52.18M
-4.01%-44.58M
23.18%-29.58M
Net Profit
-2255762.50%-721.81M
1017.50%245.84M
191.92%12.90M
140.12%5.08M
100.09%32.00K
56.59%-26.80M
61.18%-14.03M
83.17%-12.67M
33.66%-35.38M
13.71%-61.73M
14.98%-36.15M
-27.98%-75.33M
28.12%-53.33M
-302.39%-71.54M
27.69%-42.52M
-36.25%-58.86M
-15.42%-74.20M
70.61%-17.78M
-27.51%-58.80M
-11.89%-43.20M
Balance Sheet
Current assets
-8.87%373.63M
-4.18%404.35M
-16.73%355.68M
9.63%398.46M
-8.30%409.98M
-14.92%421.97M
-14.99%427.13M
-28.88%363.46M
-8.92%447.10M
-3.98%495.97M
-1.28%502.47M
3.27%511.06M
-4.07%490.88M
-8.77%516.50M
101.39%509.00M
86.17%494.85M
86.91%511.71M
74.84%566.14M
55.60%252.74M
30.40%265.80M
Total current liabilities
39.71%195.39M
22.25%196.07M
23.88%190.24M
37.26%177.16M
16.62%139.85M
6.93%160.38M
69.20%153.57M
38.04%129.06M
40.82%119.92M
42.15%149.99M
11.18%90.76M
-1.98%93.50M
5.11%85.16M
1.73%105.51M
-38.90%81.64M
-17.48%95.39M
-19.94%81.02M
-1.83%103.72M
19.53%133.61M
12.62%115.60M
Total assets
-3.12%465.05M
4.84%514.16M
-9.13%446.42M
-3.22%457.19M
2.60%480.05M
-5.13%490.42M
-6.06%491.25M
-10.84%472.42M
-8.21%467.89M
-6.01%516.96M
-6.39%522.92M
3.79%529.88M
-3.41%509.74M
-6.49%550.00M
110.19%558.59M
84.12%510.54M
85.54%527.72M
75.72%588.15M
50.81%265.76M
29.15%277.28M
Total liabilities
9.33%1.02B
-34.46%633.31M
-13.08%834.31M
-7.30%878.78M
-1.28%931.97M
-0.63%966.35M
2.77%959.82M
3.20%948.02M
12.65%944.06M
15.14%972.49M
16.56%933.91M
26.92%918.60M
21.11%838.02M
21.50%844.60M
94.10%801.25M
88.80%723.77M
92.51%691.93M
96.38%695.14M
189.51%412.81M
177.40%383.36M
Total equity
-22.55%-553.84M
74.96%-119.15M
17.22%-387.89M
11.36%-421.59M
5.09%-451.93M
-4.48%-475.93M
-14.01%-468.56M
-22.35%-475.61M
-45.05%-476.17M
-54.63%-455.53M
-69.37%-410.99M
-82.30%-388.71M
-99.91%-328.29M
-175.36%-294.60M
-65.02%-242.66M
-101.02%-213.23M
-118.99%-164.22M
-455.43%-106.99M
-537.15%-147.04M
-238.65%-106.08M
Cash Flow Statement
Net operating income
-124.56%-61.79M
5700.61%291.96M
404.84%41.62M
3119.15%41.30M
48.74%-27.52M
41.55%-5.21M
141.44%8.24M
92.73%-1.37M
-12.99%-53.68M
62.61%-8.92M
38.67%-19.90M
32.22%-18.81M
38.93%-47.51M
26.53%-23.85M
-39.39%-32.44M
-9.23%-27.76M
-27.52%-77.80M
23.68%-32.46M
39.16%-23.28M
18.14%-25.41M
Net investment
-1091.50%-268.65M
-569.11%-83.49M
59.88%13.57M
1289.34%29.13M
-5.78%27.09M
162.50%17.80M
-63.28%8.49M
87.13%-2.45M
126.85%28.76M
-136.87%-28.47M
133.24%23.12M
80.46%-19.04M
-178.41%-107.11M
794.38%77.22M
-997.68%-69.54M
-2263.37%-97.44M
-362.20%-38.47M
-151.93%-11.12M
122.74%7.75M
191.32%4.50M
Net financing
77887.15%412.55M
-5320.54%-217.96M
-4716.48%-58.81M
-3648.02%-73.69M
150.48%529.00K
-26.73%-4.02M
4.00%1.27M
-106.70%-1.97M
-120.64%-1.05M
-175.57%-3.17M
-98.40%1.23M
19870.07%29.36M
-30.98%5.08M
-98.79%4.20M
1498.09%76.33M
-96.79%147.00K
153.66%7.36M
76.57%347.42M
203.06%4.78M
-95.77%4.57M

FAQs

What is the total revenue of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 874.84M, with a year-on-year change of 450.71M.

What are the current assets of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its current assets were 404.35M, with a year-on-year change of -4.18.

What are the total assets of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total assets of BioCryst Pharmaceuticals Inc were 514.16M, with a year-on-year change of 4.84.

What are the total liabilities of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of BioCryst Pharmaceuticals Inc were 633.31M, with a year-on-year change of -34.46.

What is the total equity of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its total equity of BioCryst Pharmaceuticals Inc was -119.15M, with a year-on-year change of 74.96.

What is the net operating income of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net operating income of BioCryst Pharmaceuticals Inc was 340.99M, with a year-on-year change of 13508.93.

What is the net investment of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net investment of BioCryst Pharmaceuticals Inc was -13.69M, with a year-on-year change of -126.04.

What is the net financing of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net financing of BioCryst Pharmaceuticals Inc was -349.93M, with a year-on-year change of -5974.14.

What is the Earnings Per Share (EPS) of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was 1.26, with a year-on-year change of 392.35.

What is the net income of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net income was 263.86M, with a year-on-year change of 396.87.

What is the net margin of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was 30.16, with a year-on-year change of 252.95.

What is the gross margin of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 97.82, with a year-on-year change of 0.61.

What is the debt-to-asset ratio of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 91.11, with a year-on-year change of -46.33.

What is the Return on Assets (ROA) of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was 52.53, with a year-on-year change of 397.70.

What is the operating profit of BioCryst Pharmaceuticals Inc?

According to BioCryst Pharmaceuticals Inc's FY2025 earnings report, its operating profit was 340.99M, with a year-on-year change of 13508.93.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy